Medicare AdvantageCoverageMedium impact
MA11.023m, Hyaluronan Therapies for Osteoarthritis of the Knee
Independence Blue Cross·Orthopedics, Rheumatology, Sports Medicine +1 more·Medical Policy
Effective date
Jan 2, 2026
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA11.023m for Hyaluronan Therapies for Osteoarthritis of the Knee has been updated with an effective date of January 2, 2026. This policy change affects coverage criteria for hyaluronic acid injections used to treat knee osteoarthritis.
Action Required
By January 2, 2026: Review the complete updated policy MA11.023m on the IBX medical policy portal to understand any changes to coverage criteria, prior authorization requirements, or documentation needs for hyaluronan therapy claims. Update billing workflows and provider documentation requirements accordingly once the full policy details are reviewed.